anti-mouse Lyve-1 monoclonal antibody Anti-Mouse 100 µg

In stock

Cat-Nr.
103-M130
Size
100 µg
  €533.00

Description / anti-mouse Lyve-1 monoclonal antibody

LYVE-1 has been identified as a major receptor for HA (extracellular matrix glycosaminoglycan hyaluronan) on the lymph vessel wall. The deduced amino acid sequence of LYVE-1 predicts a 322-residue type I integral membrane polypeptide 41% similar to the CD44 HA receptor with a 212-residue extracellular domain containing a single Link module the prototypic HA binding domain of the Link protein superfamily. Like CD44, the LYVE-1 molecule binds both soluble and immobilized HA. However, unlike CD44, the LYVE-1 molecule colocalizes with HA on the luminal face of the lymph vessel wall and is completely absent from blood vessels. Hence, LYVE-1 is the first lymph-specific HA receptor to be characterized and is a uniquely powerful marker for lymph vessels themselves.

More Information

Size 100 µg
Source Rat
Isotype IgG2
Clone Nr. (#4D17)
Species Reactivity Mouse
Formulation lyophilized
Buffer PBS
Reconstitution Centrifuge vial prior to opening. Reconstitute the antibody with 500 µl sterile PBS and the final concentration is 200 µg/ml.
Stability and Storage Lyophilized samples are stable for 2 years from date of receipt when stored at -20°C. Reconstituted antibody can be aliquoted and stored frozen at < -20°C for at least six months without detectable loss of activity.
Preparation Produced from a hybridoma fused by a mouse myeloma with B cells obtained from a rat immunized with mouse LYVE-1 recombinant protein. IgG2 fraction of the culture supernatant was purified by Protein G affinity chromatography.
Antigen Mouse recombinant LYVE-1
Application WB, IHC (F)
Synonyms Lyve1; Xlkd1; Lyve-1; Crsbp-1; 1200012G08Rik
Uniprot ID Q8BHC0
Protein RefSeq NP_444477
mRNA RefSeq NM_053247

All prices plus VAT + possible delivery charges